Medicare Procedure and Patient Information
2014 Medicare Procedure Volume
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
18 |
(No ratings)
Dr. Scott S. Zamvil, MD, MD PhD is a null in San Francisco, CA specializing in psychiatry & neurology, general practice and neurology (brain & spinal cord disease). He graduated from Stanford University School of Medicine in 1988 and has 36 years of experience. Dr. Scott S. Zamvil, MD, MD PhD is affiliated with UCSF Health, UCSF Medical Group, Hill Physicians and Multiple Sclerosis and Neuroinflammation Center.
1651 Fourth Street Suite 252 UCSF Multiple Sclerosis Center
San Francisco, CA 94158
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 18 |
---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 21 |
---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 32 |
---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 19 |
---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 25 |
---|
Information about Medicare patients treated by Dr. Scott S. Zamvil, MD, MD PhD.
From 65 to 74 | 0 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 14 |
The most common conditions of Medicare patients that Dr. Scott S. Zamvil, MD, MD PhD treated during 2019 were high cholesterol.
Hypertension | 0 |
---|---|
High Cholesterol | 43 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 45 |
---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 64 |
---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, MD PhD for Medicare patients.
doctor visit | 32 |
---|
Information about Medicare patients treated by Dr. Scott S. Zamvil, MD, MD PhD.
85 and over | 0 |
---|---|
75 to 84 | 0 |
Less than 65 | 1 |
65 to 74 | 0 |
The highest averages of the most common conditions of Medicare patients that Dr. Scott S. Zamvil, MD, MD PhD treated were high cholesterol.
Hypertension | 0 |
---|---|
High Cholesterol | 4 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoporosis | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Atrial Fibrillation | 0 |
Dementia | 0 |
Cancer | 0 |
Dr. Scott S. Zamvil, MD, MD PhD graduated from Stanford University School of Medicine in 1988. He completed residency at Stanford University Medical Center. He is certified by the American Board of Psychiatry and Neurology - Neurology and has a state license in California.
Medical School: Stanford University School of Medicine (1988)
Residency: Stanford University Medical Center (1986)
Board Certification: American Board of Psychiatry and Neurology - Neurology
Licensed In: California
Dr. Scott S. Zamvil, MD, MD PhD is associated with these hospitals and organizations:
Dr. Scott S. Zamvil, MD, MD PhD does not have any reviews yet, be the first to leave a review of Dr. Scott S. Zamvil, MD, MD PhD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Scott S. Zamvil, MD, MD PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Teva Pharmaceuticals USA, Inc. |
$447,441
COPAXONE $418,645 |
LAQUINIMOD $13,911 |
68546-0142-5 $3,500 |
AZILECT $1,112 |
AJOVY $9 |
Other $10,264 |
---|---|---|---|---|---|---|
GENZYME CORPORATION |
$251,805
AUBAGIO $144,685 |
LEMTRADA $60,405 |
ALEMTUZUMAB $22,153 |
NO PRODUCT DISCUSSED $9,564 |
KEVZARA $2,759 |
Other $12,238 |
Biogen, Inc. |
$131,970
PLEGRIDY $31,240 |
TECFIDERA $26,544 |
TYSABRI $7,511 |
Vumerity $4,648 |
$62,026 |
|
Biogen Idec Inc. |
$110,363
TECFIDERA $64,585 |
AVONEX $28,208 |
PLEGRIDY $17,497 |
TYSABRI $42 |
$30 |
|
Alexion Pharmaceuticals, Inc. |
$43,035
SOLIRIS $24,903 |
$18,132 |
||||
Other |
$139,105
Non-Covered Product $20,481 |
BAF312A $16,766 |
NonCovered Product $13,260 |
MAYZENT $11,045 |
Enspryng $7,095 |
Other $70,458 |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $427,264 |
---|---|
Consulting Fee | $254,261 |
Travel and Lodging | $215,848 |
Honoraria | $197,950 |
Food and Beverage | $28,049 |
Other | $346 |
Dr. Scott S. Zamvil, MD, MD PhD has received 6 research payments totaling $319,945.
Dr. Scott Zamvil is a specialist in general practice in San Francisco, CA. Areas of expertise for Dr. Zamvil include multiple sclerosis (MS). Dr. Zamvil's professional affiliations include UCSF Medical Group and Hill Physicians. He is a graduate of Stanford University School of Medicine. For his residency, Dr. Zamvil trained at Brigham and Women's Hospital and Stanford University Medical Center.